Vol 6, No 6 (2010)
Guidelines / Expert consensus
Published online: 2011-02-24

open access

Page views 1662
Article views/downloads 10084
Get Citation

Connect on Social Media

Connect on Social Media

Recommendations for diagnostics and therapy of adult patients with malignant primary bone tumors

Piotr Rutkowski, Tomasz Mazurkiewicz, Maciej Krzakowski, Konrad Ptaszyński, Teresa Klepacka, Urszula Grzesiakowska, Sławomir Falkowski, Tomasz Świtaj, Zbigniew Nowecki, Tadeusz Morysiński, Jerzy Spindel, Ewa Chmielik, Szymon Dragan, Jerzy Nazar, Daniel Kotrych, Jan Skowroński, Anna Szumera-Ciećkiewicz, Andrzej Szafrański, Justyna Szumiło, Marta Karpik, Karol Balcerkiewicz, Roman Mazuryk, Bożena Jarosz, Magdalena Rychłowska-Pruszyńska, Marta Rzeszutko, Andrzej Nowakowski
Onkol. Prak. Klin 2010;6(6):355-369.

Abstract

Bone sarcomas comprise a heterogenous group of rare mesenchymal tumors (less than 0.5% of malignant neoplasms in adults). From clinical point of view they can be divided into two main groups: spindle-cell sarcomas (osteosarcomas, majority of chondrosarcomas and less common subtypes) and small-cell sarcomas (mainly Ewing family of tumors). Correct diagnosis and effective therapy is performed by cooperation of radiologists, oncological and orthopedics surgeons, clinical oncologists, radiotherapists, rehabilitants, pathologists, nuclear medicine specialists and molecular biologists. The most important principle in diagnostics and therapy of primary malignant bone tumors is multidisciplinary work in experienced centers. Improvement of diagnostics, implementation of combined therapy and technological developments caused the increase of limb-sparing surgery indications and better long-term results of their treatment.

Onkol. Prak. Klin. 2010; 6, 6: 355–369

Article available in PDF format

View PDF (Polish) Download PDF file

References

  1. Bacci G, Picci P, Ruggieri P. Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities. Cancer. 1990; 65: 2539–2553.
  2. Dorfman H, Czerniak B. Bone cancers. Cancer. 1995; 75(S1): 203–210, doi: 10.1002/1097-0142(19950101)75:1+<203::aid-cncr2820751308>3.0.co;2-v.
  3. Grier HE. The Ewing family of tumors. Ewing's sarcoma and primitive neuroectodermal tumors. Pediatr Clin North Am. 1997; 44(4): 991–1004.
  4. Hohendoorn PCW. on behalf of the ESMO/EUROBONET Working Group. Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010(supl. 5): v204–v213.
  5. Ruka W. Pierwotne nowotwory złośliwe kości u dorosłych. In: Krzakowski M. ed. Onkologia kliniczna. Borgis, Warszawa 2006.
  6. Spanier SS, Shuster JJ, Vander Griend RA. The effect of local extent of the tumor on prognosis in osteosarcoma. J Bone Joint Surg Am. 1990; 72(5): 643–653.
  7. Yasko AW, Johnson ME. Surgical management of primary bone sarcomas. Hematol Oncol Clin North Am. 1995; 9(4): 719–731.
  8. NCCN Clinical Practice Guidelines in Oncology. Bone Cancer Wersja. : Wersja 3.10.